Welcome to OncBioMune Pharmaceuticals Inc. We are a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology that is designed to stimulate the immune system to selectively attack cancer cells without harm to the patient.  The vaccine technology has been proven safe through use in more than 300 patients